Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of Breath Volatile Organic Compounds (VOCs) in Early Detection of Acute Pulmonary Exacerbations in Cystic Fibrosis

NCT05944367 is registered in ClinicalTrials.gov with Papworth Hospital NHS Foundation Trust as lead sponsor.

NCT NCT05944367
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05944367 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of Breath Volatile Organic Compounds (VOCs) in Early Detection of Acute Pulmonary Exacerbations in Cystic Fibrosis
Lead sponsor
Papworth Hospital NHS Foundation Trust
Phase
Observational
Overall status
Completed
Start date
October 13, 2021
Completion date
December 23, 2022
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cystic fibrosis